PacBio appoints COO Mark Van Oene as new CEO after Christian Henry steps down

PacBio announced that its chief operating officer, Mark Van Oene, will become president and chief executive officer effective Aug. 5 and will join the company's board.

Van Oene, who joined PacBio in 2021, has overseen operations, commercial strategy, product development and AI-related improvements. Earlier this year he temporarily took over sales and customer support while former CEO Christian Henry handled operations and R&D.

Christian Henry, who led PacBio for six years, will remain a director and serve as a business adviser through the end of 2026. The company did not disclose a reason for his departure but said the new leadership will focus on boosting sales, expanding clinical applications and cutting costs.